Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
B830 refers to a specific light-harvesting complex 2 (LH2) found in certain purple photosynthetic bacteria, such as Marichromatium purpuratum. It is characterized by its primary absorption maximum at approximately 830 nm, which is attributed to the electronic excitations of bacteriochlorophyll a pigments arranged within the protein matrix. The complex functions to capture solar energy and efficiently transfer it to the photosynthetic reaction center to drive the conversion of light into chemical energy. While B830 is a critical component of bacterial photosynthesis and a subject of extensive biophysical research, it is not a therapeutic target in human medicine, nor is it associated with human disease or drug interactions.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Light-harvesting complex 2 (LH2) B830 (LH2-B830).